BD Micro-Fine Pen needles

BD Micro-Fine pen needles are a prominent brand in the medical supplies market, specifically designed for individuals managing diabetes. The brand was originally created by Becton, Dickinson and Company (BD), an American medical technology firm founded in 1897. These high-precision needles are engineered for compatibility with various delivery devices including those from Novo Nordisk, Eli Lilly, and Pfizer.

While BD operates a global manufacturing network, their insulin pen needles for the European and International markets are primarily manufactured in their state-of-the-art facility in Dun Laoghaire, Ireland. In 2022, BD completed a spin-off of its diabetes care business into an independent, publicly traded company named Embecta. Consequently, Embecta is now the ultimate owner of the brand, continuing the legacy of manufacturing these essential medical components with a focus on global health and patient comfort.